Director, Head of Program Management
Tessera Therapeutics
Somerville, Massachusetts
Full-Time
$186,000
OfficeDirector
You are an experienced program management leader who brings strategic thinking, operational discipline, and a collaborative leadership style to complex drug development programs. You understand how to translate scientific and development strategy into clear, executable plans, and you are energized by helping teams make progress through structure, transparency, and effective decision-making.
You are comfortable working with senior leaders while also staying close enough to the details to understand risks, dependencies, tradeoffs, and the critical path. You know how to influence without authority, build trust across functions, and create alignment in a matrixed environment. You are an active listener and clear communicator who can synthesize complex information into practical recommendations that help teams and leaders make timely decisions.
You bring positive energy and a continuous-improvement mindset. You are motivated by the opportunity to build and lead a Program Management function that enables innovation, accountability, and high-quality execution in service of bringing meaningful therapies to patients.
Tessera leaders are empathetic and transparent coaches with a strong sense of integrity. They are committed to the growth and development of their teams, the organization and themselves.
All inquiries regarding the posted position should be directed to the Talent Partner (see below). Interested individuals must apply directly to be considered for the opening.
John Pierciey, Vice President, Program Lead
John is the program lead for Tesseras sickle cell disease (SCD) and alpha-1 antitrypsin programs.
Prior to joining Tessera, John spent more than 13 years at bluebird bio, where he held roles spanning research, manufacturing, process development, clinical, and corporate development. He led process development and clinical pharmacology characterization efforts for three gene therapy products from preclinical development through commercial launch, including treatments for -thalassemia (Zynteglo) and SCD (Lyfgenia). John received a masters degree in Cell and Molecular Biology from the University of Pennsylvania and bachelors degrees in Biology and Chemistry from Roger Williams University
Meet our Leadership Team and Board of Directors
Ben Hoogheem Senior Director, Head of Talent Management
As Head of Talent Management at Tessera Therapeutics, Ben leads Tesseras talent strategy across talent acquisition, performance management, and talent mobility.
Ben began his career as an in vivo Pharmacologist, which gave him a lasting appreciation for the rigor, creativity, and collaboration that drive scientific discovery. That foundation continues to shape how he helps build organizations designed to enable science thrive.
Ben is focused on aligning exceptional people with bold science creating the structure, clarity, and culture that empower teams to scale effectively and achieve meaningful impact.
The stated base salary range represents Tesseras good-faith estimate for this role. Actual compensation will be determined based on a number of factors, including but not limited to individual qualifications, years of relevant experience, internal compensation alignment, and external market data.
Tessera offers a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness, and financial security of our employees and their families. Benefits currently include group medical, vision, and dental coverage; group life and disability insurance; a 401(k) plan with company contribution; tuition reimbursement; and more.
This position is also eligible for an annual incentive bonus and equity grants as part of Tesseras total rewards program.
Per Year Salary Range: $186,000 - $239,000 USD
Tessera Therapeutics is pioneering Gene Writing a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy.
Tessera is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability status, marital status, genetics, protected veteran status, citizenship status, sexual orientation, gender identity or expression, or any other characteristic identified by federal, state, or local laws where we operate. Tessera provides reasonable accommodations to qualified applicants and employees with disabilities. To begin an interactive dialogue with Tessera regarding a reasonable accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied, please contact the recruiter or Accommodations@tesseratx.com
Recruitment & Staffing Agencies: Tessera Therapeutics does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Tessera Therapeutics or its employees is strictly prohibited unless contacted directly by Tessera Therapeutics internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Tessera Therapeutics, and Tessera Therapeutics will not owe any referral or other fees with respect thereto.